Clinical trial
Detrol Long Acting (LA) vs Estrace Vaginal Cream for the Treatment of Overactive…
NCT00465894 · University of Alabama at Birmingham, Other · Completed
Key facts
| NCT number | NCT00465894 |
|---|---|
| Title | Detrol Long Acting (LA) vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms |
| Official title | Randomized Controlled Trial of Tolterodine in Combination With or Without Low-Dose Intravaginal Estradiol Cream for the Treatment of Overactive Bladder in Post-Menopausal Women |
| Acronym | DRIVE |
| Lead sponsor | University of Alabama at Birmingham, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Overactive Bladder |
| Intervention type | Drug |
| Interventions | Extended Release Tolterodine LA, Intra Vaginal Estradiol Cream |
| Enrollment | 58 |
| Start date | Apr 1, 2007 |
| Primary completion | Jul 1, 2010 |
| Completion | Dec 1, 2011 |
| First posted | Apr 25, 2007 |
| Last update posted | Nov 1, 2018 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: